Display search results for ** instead (282 products)

Showing 1-10 of 282

Globally, nations are experiencing a decline in population growth rate accompanied by fall in mortality rate, increase in life expectancy and improvement in health condition. However, these trends have resulted in an increase in percent of aged people in the total population or an Aging Society. The segment gives an overview of the common demogra...

USD 1,500.00

USD 1,125.00 save 25 %

Expiring patents on revenue generating drugs, competition from generic drugs and increasing research and development cost, is forcing pharmaceutical manufacturers to often outsource drug discovery processes. Over the years pharmaceutical outsourcing has moved up the value chain from non core functions to even core functions. The segment gives an ov...

USD 1,500.00

USD 1,125.00 save 25 %

Though most countries were affected by the current economic slowdown, the impact varied from country to country. The article looks into the affect of slowdown in six emerging countries, namely Brazil, Russia, China, India, Mexico and Poland and covers the highlights of economic stimulus measures adopted by these countries. The article also provides...

USD 1,500.00

USD 1,125.00 save 25 %

The global economic slowdown affected almost every nation across the globe, though, the impact varied from country to country. The article discusses the healthcare system, current healthcare related issues and recent health sector initiatives in five developed nations, namely the United States, Japan, Germany, France and United Kingdom. In addition...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on May 4, 2009, provides a strategic overview of changing strategies in molecular imaging and computed tomography. Additionally, a company spotlight is provided for Digirad, a leading designer, developer and manufacturer of solid state gamma cameras and a provider of in-office cardiology imaging programs. Reimbur...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on May 11, 2009, provides a strategic overview of advances in bioprosthetic technologies. Additionally, a company spotlight is provided for Cardiac Dimensions, an emerging medical device company focused on minimally invasive products for the treatment of mitral regurgitation. Reimbursement and regulatory news fro...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on June 8, 2009, provides a strategic overview of the impact of the credit crunch on capital imaging equipment purchasing and the U.S. Computed Tomography Market. Additionally, a company spotlight is provided for Bycast, a leading provider of storage visualization software for large-scale digital archives and sto...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on June 15, 2009, provides a strategic overview of trends in the use of catheter ablation technologies in the treatment of Atrial Fibrillation. This information is based on Frost & Sullivan research with Electrophysiologists, General Cardiologists, and Cardiac Surgeons. Additionally, a company spotlight is provid...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on June 29, 2009, provides a strategic overview of trends and dynamics in the hospital market for electronic fetal monitoring. Additionally, a company spotlight is provided for RF Technologies, a company which provides a comprehensive portfolio of integrated RFID solutions. Reimbursement and regulatory news from ...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 1-10 of 282